Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul 1;9(13):1253-60.
doi: 10.4103/1673-5374.137570.

Stem cell therapy for central nerve system injuries: glial cells hold the key

Li Xiao  1 , Chikako Saiki  2 , Ryoji Ide  2
Affiliations
Review

Stem cell therapy for central nerve system injuries: glial cells hold the key

Li Xiao et al. Neural Regen Res. .

Abstract

Mammalian adult central nerve system (CNS) injuries are devastating because of the intrinsic difficulties for effective neuronal regeneration. The greatest problem to be overcome for CNS recovery is the poor regeneration of neurons and myelin-forming cells, oligodendrocytes. Endogenous neural progenitors and transplanted exogenous neuronal stem cells can be the source for neuronal regeneration. However, because of the harsh local microenvironment, they usually have very low efficacy for functional neural regeneration which cannot compensate for the loss of neurons and oligodendrocytes. Glial cells (including astrocytes, microglia, oligodendrocytes and NG2 glia) are the majority of cells in CNS that provide support and protection for neurons. Inside the local microenvironment, glial cells largely influence local and transplanted neural stem cells survival and fates. This review critically analyzes current finding of the roles of glial cells in CNS regeneration, and highlights strategies for regulating glial cells' behavior to create a permissive microenvironment for neuronal stem cells.

Keywords: CNS injury; Neuron regeneration; glial cells; microenvironment; oligodendrocyte regeneration; stem cell therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: None declared.

Figures

Figure 1
Figure 1
Glial cells and neurons in the healthy central nerve system.
Figure 2
Figure 2
Damaged central nerve system microenvironment. ECM: Extracellular matrix; ROS: reactive oxygen species; NG2: neuron-glial antigen 2.
See this image and copyright information in PMC

References

    1. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002;200:629–638. - PMC - PubMed
    1. Almad A, Sahinkaya FR, McTigue DM. Oligodendrocyte fate after spinal cord injury. Neurotherapeutics. 2011;8:262–273. - PMC - PubMed
    1. Amaral AI, Meisingset TW, Kotter MR, Sonnewald U. Metabolic aspects of neuron-oligodendrocyte-astrocyte interactions. Front Endocrinol (Lausanne) 2013 doi: 10.3389/fendo.2013.00054. - PMC - PubMed
    1. Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154–169. - PMC - PubMed
    1. Aronson AL. Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc. 1980;176:1061–1068. - PubMed